{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.1049",
  "meta" : {
    "versionId" : "15",
    "lastUpdated" : "2024-01-23T15:46:53.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "NCQA PHEMUR Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-01-23"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-01-23"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1049",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.1049"
    }
  ],
  "version" : "20240123",
  "name" : "PotentiallyHarmfulAntiparkinsonianAgentsForOlderAdults",
  "title" : "Potentially Harmful Antiparkinsonian Agents for Older Adults",
  "status" : "active",
  "date" : "2024-01-23T01:10:32-05:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful antiparkinsonian agents for older adults as described in the 2023 American Geriatrics Society BEERS criteria),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications. Includes Benztripine and Trihexyphenidyl medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1251"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:66578832-ca9f-4701-8316-0f2f3de22db3",
    "timestamp" : "2024-11-09T01:14:06-05:00",
    "total" : 6,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "885209",
        "display" : "benztropine mesylate 2 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "885213",
        "display" : "benztropine mesylate 1 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "885219",
        "display" : "benztropine mesylate 0.5 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "905269",
        "display" : "trihexyphenidyl hydrochloride 2 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "905273",
        "display" : "trihexyphenidyl hydrochloride 0.4 MG/ML Oral Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "905283",
        "display" : "trihexyphenidyl hydrochloride 5 MG Oral Tablet"
      }
    ]
  }
}
